Beware: 'Zombie ETFs' Lurking

Rarely or never traded products pose a danger for naive investors stumbling about their choices. Analysis

Biotech ETFs: Appraising The Pipelines

Parsing the performance and holdings of different biotech funds. Analysis

ETF Industry’s Tower Of Babel

Misleading terms and confusing acronyms continue. Analysis

Thematic ETFs The New Sectors?

Sometimes an idea just gets you thinking about the possibilities. Analysis

Insurance Firms Using ETFs More

There’s significant room for ETF growth within insurance companies. Analysis

ETFs By Any Other Name

Giving ETFs new names is a little like trying to make 'fetch' happen. Analysis

Smaller ETF Issuers Unlock Diversification

The ETF biz is a concentrated one, but there’s room to stand out among well-established giants. Analysis

QQQ Joins An Elite Club

The fund that tracks the Nasdaq-100 Index has marked a key milestone.